Cited by 511Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record, with a small difference in title or year; 61 of the 62 references it cites were found in a registry or an index.

Impact of Lipids on Cardiovascular Health

Open access

Ference, Brian A., Graham, Ian, Tokgozoglu, Lale, Catapano, Alberico L.·2018·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2018.06.046

Open this paper in CoChat — free account Open PDF

Abstract

People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular disease. Therefore, encouraging people to achieve ideal cardiovascular health represents an important opportunity to improve the prevention of cardiovascular disease. However, preventing cardiovascular disease by promoting ideal cardiovascular health requires shifting the focus from treating disease after it develops to preventing cardiovascular events before they happen by slowing the progression of atherosclerosis. Because atherogenic lipoproteins play a central causal role in the initiation and progression of atherosclerosis, maintaining optimal lipid levels is necessary to achieve ideal cardiovascular health. This review describes the cumulative effect of lipid-carrying lipoproteins on the risk of cardiovascular disease, estimates the magnitude of the clinical benefit that can be achieved by maintaining optimal lipid levels, identifies the most effective timing for implementing strategies designed to achieve optimal lipid levels, and provides a clinical pathway to help people achieve the lipid levels necessary for ideal cardiovascular health.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.06.046

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citation
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290

Show all 62 references

Sorted by citations

Items 401–500 of 510

Statin-induced myopathy – a challenge for patients and physicians
Angelescu, G. A., Toma, M. M., & Varlas, V. N. (2021) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2021.2.7
Incorporation of biochemical parameters and diagnostic algorithms in the laboratory computer system for the early detection of lipid abnormalities from the lipid units
Velilla, T. A., Estruch, E. B., Garrido, J. R., Jiménez, M. R., Sánchez, G. M. V., & Rico, I. V. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.11.001
Hart- en vaatziekten
Rouwet, E. V., & Hofstra, L. (2022) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2761-4_5
Koronare Herzkrankheit – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung
Löllgen, H. (2019) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_42-1
Use of statins and other lipid-modifying agents across pregnancy – a nationwide drug utilization study of 822 071 pregnancies in Norway in 2005-2018Preprint
Christensen, J. J., Bogsrud, M. P., Holven, K. B., Retterstøl, K., Veierød, M. B., & Nordeng, H. (2022) · medRxiv · doi:10.1101/2022.06.28.22276237
Atherosklerose im Kindesalter
Schwab, K. O., & Doerfer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-63320-5_2
Cumulative Exposure to Oxidized Low-Density Lipoprotein is a Potential Predictor for Prognosis in Acute Ischemic Stroke: A Cohort StudyPreprint
Kaili, C., Chen, X., Luo, Y., Sun, W., Yang, X., Huang, S., Wang, Y., & Wu, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1955744/v1
Cholesterol: how to measure and how to treat
Pottle, A. (2022) · Practice Nursing · doi:10.12968/pnur.2022.33.10.402
Analysis of Clinical and Biochemical Characteristics of Patients With Genetically Confirmed Familial Hypercholesterolemia in Russian North Western District Residents
Korneva, V. A., Zakharova, F. M., Мандельштам, М. Ю., Bogoslovskaya, T. Y., Orlov, A. V., Vasilyev, V. B., & Kuznetsova, Т. Y. (2022) · Kardiologiia · doi:10.18087/cardio.2022.11.n2232
Lipidmanagement 2022 – von der Tradition zur Innovation
Reibis, R. K. (2023) · Aktuelle Kardiologie · doi:10.1055/a-2005-5248
Correlation analysis of cancer incidence after pravastatin treatment
Yu, J. S., Kim, R., Shinn, J., Park, M. Y., & Kim, H. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e6
Peer Review #3 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.1)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.1/reviews/3
Peer Review #2 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.1)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.1/reviews/2
Peer Review #1 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.1)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.1/reviews/1
Peer Review #1 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.2)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.2/reviews/1
Peer Review #3 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.2)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.2/reviews/3
Peer Review #3 of "Characterization of gut microbiota in adults with coronary atherosclerosis (v0.3)"
(2023) · PeerJ · doi:10.7287/peerj.15245v0.3/reviews/3
New approaches in the pharmacotherapy of dyslipidemia and atherosclerosis
Maksimov, M. L., Shnaider, K. O., & Zvegintseva, A. A. (2023) · doi:10.33920/med-13-2303-01
Abdominal Aortic Intima-Media Thickness in Infants at 6 Weeks of Age as an Early Life Marker of Atherosclerosis: A Longitudinal Twin Birth Cohort StudyPreprint
Zhang, Q., Luan, X., Yuan, X., & Qi, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3270712/v1
Bringing Human Serum Lipidomics to the Forefront of Clinical Practice: Two Clinical Diagnosis Success Stories
Amigó, N., & Betes, P. O. (2023) · Springer eBooks · doi:10.1007/978-981-99-5162-8_12
ASSOCIATIONS OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL WITH BIOMOLECULES IN METABOLIC DISORDERS IN YOUNG PEOPLE AGED 25–44 YEARS
Kashtanova, E. V., Polonskaya, Y. V., Shcherbakova, L. V., Stakhneva, E. M., Шрамко, В. С., Spiridonov, A. N., & Ragino, Y. I. (2023) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2023-12-3-152-160
A critical look at the new possibilities of therapeutic use of statins – a summary of the current state of knowledge
Kossakowski, K., Orzechowska, K., Sikora, W., Grabowska, W., Kowalska, K., Kujawski, R., Czora-Poczwardowska, K., Szulc, M., Mikołajczak, P. Ł., & Bartkowiak-Wieczorek, J. (2023) · Farmacja Polska · doi:10.32383/farmpol/174070
Calidad intrínseca de la carne de llama (Lama glama) de la Puna de Jujuy criada en pastos con dos niveles de suplementación de granos.
Labarta, F. E., Farfán, N. B., Chavarria, N., Echenique, M., Quintana, A. L., Verrastro, G. E., Godoy, M. D., Zimerman, M., & Grigioni, G. (2023) · Archivos Latinoamericanos de Producción Animal · doi:10.53588/alpa.310304
Glycemic Control Is Associated with Lipid Profile and Atherogenic Index of Plasma in Type 2 Diabetes MellitusPreprint
Daneshvar, M., Naddafi, M., & Ghadimi, M. (2024) · Qeios · doi:10.32388/a433s7.2
Glycemic Control Is Associated with Lipid Profile and Atherogenic Index of Plasma in Type 2 Diabetes MellitusPreprint
Daneshvar, M., Naddafi, M., & Ghadimi, M. (2024) · Qeios · doi:10.32388/a433s7
Stable Lipid Management: Standing on Solid Ground
Lee, H. J., & Yoon, H. (2024) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e7
Análise metabolômica em mulheres jovens com artrite idiopática juvenil
Tomioka, R. B. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-15022024-124438
Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction
Graham, I. M. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae099
Self-citation
Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?
Martínez‐Hervás, S., Real, J. T., Carmena, R., & Ascaso, J. F. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2024.03.002
Cumulative Exposure to Oxidized Low-density Lipoprotein is a Potential Predictor for Prognosis in Acute Ischemic Stroke: A Cohort Study
Cheng, K., Chen, X., Luo, Y., Sun, W., Yang, X., Huang, S., Wang, Y., & Wu, D. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128280291240220093912
Cardiovascular risk prediction - now and the future
Graham, I. M. (2024) · European Atherosclerosis Journal · doi:10.56095/eaj.v3i1.61
Self-citation
Efficacy and safety of Pemafibrate administration in patients with dyslipidemia: A Systematic Review and Updated Meta-analysis of Randomized Controlled Trials.Preprint
Elbahloul, M. A., Elgadi, A. T., Fayed, H., Ramadan, M., Kasser, M. E., Hussein, A., & Labieb, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4486419/v1
Dyslipoproteinemias in postmenopausal women and new therapeutic targets
Galván, E. E. R. (2024) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2024.15.00755
Rethinking Cholesterol Screening and Management in Young Adults
Zhang, Y., Pletcher, M. J., & Moran, A. E. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.029
Genetic methods to evaluate evidence for causal effect of coffee on health
Pham, K., & Hyppönen, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00040-5
The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and bone mineral density in US adults: NHANES (2011-2018)Preprint
Sun, Z., Yue, Y. G., & Li, P. (2024) · Research Square · doi:10.21203/rs.3.rs-4969279/v1
The impact of diabetes mellitus and HBV infection on major adverse cardiovascular events related to statin use for Chinese population with cardiovascular diseasePreprint
Wu, Q., He, X., Tong, X., Li, Y., & Wang, X. (2024) · medRxiv · doi:10.1101/2024.11.05.24316797
Exploring the Potential Health and Economic Benefits of Optimized Low-Density Lipoprotein Cholesterol Management in Malaysia’s Atherosclerotic Cardiovascular Disease Population: A Model-Based Analysis
Foo, C. Y., Mansor, N., Erng, T., Mohamed, M. S., Mahadevan, G., Lau, G. S. K., Ranga, A., & Ong, T. K. (2024) · Value in Health Regional Issues · doi:10.1016/j.vhri.2024.101059
Importance of Dyslipidemia Prevention and Management in Health Checkups
Eguchi, J. (2024) · Health Evaluation and Promotion · doi:10.7143/jhep.51.518
Ether-linked phospholipidomic profiling unveils novel lipid fingerprints and algorithm predicts the future development of carotid plaques in postmenopausal women: a population-based cohort studyPreprint
Xuan, Q., Li, Q., Lu, Y., Du, X., Ma, X., Xu, Y., & Sun, Q. (2025) · Research Square · doi:10.21203/rs.3.rs-5738378/v1
Agreement Between Cardiovascular Risk Stratification Instruments in Geriatric Patients
Colombo, M. P. R., Ubiali, L. G., Keller, G. S., Grings, L. R., & Salvaro, R. G. (2025) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20230159
Dyslipidemia in children and adolescents with CKD G1-G5, on dialysis and after transplantation: a narrative review of clinical studies and practical guidelines
Николаевна, К. Е., & Baiko, S. (2025) · Nephrology and Dialysis · doi:10.28996/2618-9801-2025-1-38-58
RESIDUAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN STATIN USERS - A SYSTEMATIC REVIEW AND META-ANALYSIS
Watanabe, A. H., Bash, L. D., Westley, T., Aiello, E., Bradbury, J., García, A., Garg, J., Telukuntla, V., & Nanna, M. G. (2025) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(25)00988-x
Familial Hypercholesterolemia in Women: Assessment, Diagnosis, and Treatment
Demeter, S. H., & Lew, K. (2025) · Clinical Journal for Nurse Practitioners in Women s Health · doi:10.1891/cjnpwh-2505
Addressing Dyslipidaemia in Advanced CKD: Insights from a Secondary Care Cohort
Siby, T., Babu, S., Patabendi, I., Ramachandran, S., & Baharani, J. (2025) · Hearts · doi:10.3390/hearts6020014
Significance of Diet Therapy in the Development and Treatment of Cardiovascular Diseases
Fujioka, Y. (2025) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.78.151
Demystifying the nuances of the lipid patient: a guide for primary care providers
Myerson, M. L., Gillett, K., O’Hara, J., Potter, R., & SKOLNIK, N. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101070
Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Musa‐Veloso, K., Gauntlett, C., Geronimo, K., Vicente, I., & Ho, S. P. L. (2025) · Nutrients · doi:10.3390/nu17172791
Recurrent coronary events as a persistent challenge in cardiology. The role of PCSK9 inhibitors in respect of this issue through the example of a local program implemented in St. Petersburg
Hoang, V. B., Koltsov, A. V., Kachnov, V. A., Makhova, O. A., Sarana, А. М., & Tyrenko, V. V. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252809178
Biyokimyanın Kişiselleştirilmiş Tıptaki Öncü Rolü: Moleküler Bilgiden Klinik Uygulamalara
Calayır, F., Kaptanoğlu, S., & Kul, A. R. (2025) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub933.c3917
Effects of different exercises on body composition and blood lipids in normal weight obesity: A meta-analysis
Peng, N., Ouzhu, N., Yang, J., Zhai, G., & Li, J. (2025) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2025.09.002
Machine Learning–Based CCTA-Guided Intensive Atheroprotective Strategy in a Middle-Aged INOCA Patient With Challenging Arterial Features
Kharlamov, A., McElhinney, P. A., Kitslaar, P. H., Gaibazzi, N., Guglielmo, M., van der Harst, P., Babunashvili, A. M., Sozykin, A., Dey, D., & Pontone, G. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.105907
Warum ist der Legacy-Effekt bei der Lipidsenkung so wichtig?
Gielen, S. (2025) · CardioVasc · doi:10.1007/s15027-025-3920-0
Efficacy and Safety of Bempedoic Acid Added to Intensive Lipid-Lowering Therapy in Patients With chronic coronary syndrome: Real-World Clinical ExperiencePreprint
Gómez-Barrado, J. J., Ramos, Y. P., Jiménez-Baena, E., Fernández-Chamorro, A. I., & Gómez-Turégano, P. (2025) · Research Square · doi:10.21203/rs.3.rs-8330715/v1
Additional file 1 of Age and sex are associated with the plasma lipidome: findings from the GOLDN study
Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Figshare · doi:10.6084/m9.figshare.14369900
Additional file 1 of Poor cardiovascular health status among Chinese women
Han, T.-W., Liu, Y.-Q., Dong, W., Bai, X.-J., Liu, Y.-Y., Su, X., Li, Y.-M., Qian, J.-Y., 项美香, Cai, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13290875
Additional file 2 of Moderating effect of a sodium-rich diet on the association between long-term exposure to fine particulate matter and blood lipids in children and adolescents
Cao, Y., Liu, Y., Ma, M., Cai, J., Liu, M., Zhang, R., Jiang, Y., Yan, L., Cao, Y., Liu, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26341963
Additional file 2 of Poor cardiovascular health status among Chinese women
Han, T.-W., Liu, Y.-Q., Dong, W., Bai, X.-J., Liu, Y.-Y., Su, X., Li, Y.-M., Qian, J.-Y., 项美香, Cai, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13290878
Additional file 2 of Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., Roeters van Lennep, J. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14411699
Additional file 1 of The associations between p,p’-DDE levels and plasma levels of lipoproteins and their subclasses in an elderly population determined by analysis of lipoprotein content
Jugan, J. A., Lind, P., Salihovic, S., Stubleski, J., Kärrman, A., Lind, L., & Merrill, M. A. L. (2020) · Figshare · doi:10.6084/m9.figshare.13346230
Additional file 3 of Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., Roeters van Lennep, J. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14411702
Additional file 1 of Moderating effect of a sodium-rich diet on the association between long-term exposure to fine particulate matter and blood lipids in children and adolescents
Cao, Y., Liu, Y., Ma, M., Cai, J., Liu, M., Zhang, R., Jiang, Y., Yan, L., Cao, Y., Liu, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26341930
Additional file 2 of Age and sex are associated with the plasma lipidome: findings from the GOLDN study
Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Figshare · doi:10.6084/m9.figshare.14369903
Additional file 1 of The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL
Wu, Z., Huang, Z., Lichtenstein, A. H., Liu, Y., Chen, S., Jin, Y., Na, M., Bao, L., Wu, S., & Gao, X. (2021) · Figshare · doi:10.6084/m9.figshare.14788405
Additional file 1 of Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., Roeters van Lennep, J. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14411696
Additional file 3 of Age and sex are associated with the plasma lipidome: findings from the GOLDN study
Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Figshare · doi:10.6084/m9.figshare.14369906
Additional file 5 of Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., Roeters van Lennep, J. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14411708
Additional file 1 of Effect of low-density lipoprotein level and mortality in older incident statin-naïve hemodialysis patients
Song, J. H., Park, E. H., Bae, J., Kwon, S. H., Cho, J.-H., Yu, B. C., Han, M., Song, S. H., Ko, G.-J., Yang, J. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24234188
Additional file 4 of Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., Roeters van Lennep, J. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14411705
Research Progress on Inclisiran, a Small Interfering RNA, in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
刘, 美. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113273
Modeling the Interplay of Ghrelin, Leptin, and Exercise on Energy Balance: A Systems Dynamics Approach
Chudtong, M., Nagy, I., & Gaetano, A. D. (2025) · IEEE International Symposium on Computational Intelligence and Informatics (CINTI) · doi:10.1109/cinti67731.2025.11311736
Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response
Sun, Z., Hong, Y., Hong, Y., Xin, C., Liu, Q., Hu, H., Yh, S., Chen, Y., Liu, S., Shen, Y., et al. (2026) · Lipids · doi:10.1002/lipd.70034
Method Comparison of Dried Blood Spot and Plasma Apolipoprotein B Measurement on a Semi‐Automated Analyser: Toward Accessible Lipid Profiling in Resource‐Limited Settings
Pitampersad, B., Madurai, S., Manivannan, B., Pillay, K., & Mahomed, S. (2026) · Analytical Science Advances · doi:10.1002/ansa.70067
Epidemiology of Atherosclerotic Cardiovascular Disease
Penz, C. S., & Lieb, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00084-4
Développement d'un réacteur innovant de type monolithe pour l'hydrogénation sélective d'huile végétale
Albrand, P. (2020) · theses.fr (ABES) · doi:10.70675/05c0c037z614ez4bcbzaacez3accb30847c1
Dyslipidaemia and cardiovascular risk – Key considerations in South Asians
Chauhan, A., Sahota, S., Jegatheeswaran, L., Johal, H. K., Minhas, R., Patel, P., Gupta, P., Patel, V., Banerjee, A., Patel, K., et al. (2026) · Clinical Medicine · doi:10.1016/j.clinme.2026.100571
Ischaemic stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis in China (PROMISE): a multivariable prediction model development and validation study
Hou, C., Dong, X., Liu, Y., Ma, X., Guo, X., Wang, C., Chu, X., Luo, J., Zhang, W., Yu, E., et al. (2026) · The Lancet Digital Health · doi:10.1016/j.landig.2026.100989
Statin-dependent coupling between circulating atherogenic lipoproteins and lesion-level plaque lipid burden assessed by NIRS-IVUS
Park, S., Kim, W., Kook, H., & Lim, Y. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.026
Genetic modifiers of the Portfolio Diet Score and LDL cholesterol in young adults
Chen, V., Chiavaroli, L., Glenn, A. J., Kavanagh, M. E., Zeitoun, T., Kendall, C. W. C., Jenkins, D., Mahdavi, S. M., El‐Sohemy, A., & Sievenpiper, J. L. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104797
Improving adherence to guideline-based lipid-lowering therapy in people with hyperlipidemia using a targeted educational outreach approach
Conley, E. L., Chang, S. M., Jones, L. K., Kalich, B. A., Patterson, G., Payne, N., Beard, S., Judie, K. S., & Kelley, T. (2026) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2026.26004
TyHGB and CVD high-risk stratification: nonlinear association and discrimination in the ChinaHEART Luohe study
Huang, Z., Cai, J., Bai, J., Wu, L., Huang, Y., Guo, L., Wang, J., Zhao, G., Xie, Q., & Wang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1818472
Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics
Blanco-Echevarría, A., Segovia, R. C., Herraiz, C. G., Izquierdo, B. G., Guadalix, S., Carreras, M. P., Gil, Y. R., Martínez, M. D. C., Amigó, N., D’Avola, D., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343134 · Cited by 1
Myrtle berry juice improves hematological parameters and alleviates oxidative stress and inflammation in the myocardium of rats fed a high‐fat diet: A combined in vivo and in silico investigation
Hajaji, S., Jabri, M., Arrari, F., & Sebaï, H. (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70735
The cardiometabolic grey zone in young adults: clinical thresholds, cumulative exposure, and long-term cardiovascular risk
Ciuceis, C. D., & Rizzoni, D. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag271
The Complex Relationship Between HDL/LDL Cholesterol, Stroke and Cardiovascular Disease
Parker, M., Novakovic, T., Rastović, M. K., Benković, V., & Gutiérrez‐Ibarluzea, I. (2026) · Healthcare · doi:10.3390/healthcare14101371
Manejo práctico de la terapia hipolipemiante en el ictus y ataque isquémico transitorio: consenso y recomendaciones prácticas
Freijo, M. D. M., Cardona, P., Castellanos, M., de Torres-Chacón, R., Gil-Núñez, A., Guillán, M., Martínez‐Sánchez, P., Palacio-Portilla, E. J., Purroy, F., Segura, T., et al. (2026) · Neurología · doi:10.1016/j.nrl.2026.502076
Food‐grade proteins, lipids, and fibers as potential tools to ameliorate cardiovascular disorders: A review
Shanmugam, S., Begum, R., Shanmugasundaram, N., Prajapati, B., Singh, S., Nagenthran, P., Singh, S., & Rajesh, K. (2026) · Food Biomacromolecules · doi:10.1002/fob2.70071
Consensus statement and clinical recommendations on the practical management of lipid-lowering therapy in stroke and transient ischaemic attack
Freijo-Guerrero, M., Cardona, P., Castellanos, M., de Torres-Chacón, R., Gil-Núñez, A., Guillán, M., Martínez-Sánchez, P., Palacio-Portilla, E. J., Purroy, F. F., Segura, T., et al. (2026) · Neurología (English Edition) · doi:10.1016/j.nrleng.2026.502076
Association of long-term exposure to lower low-density lipoprotein cholesterol with neuroimaging metrics: A population-based cohort study
Sun, J., Hui, Y., Li, J., Zhao, X. L., Zhao, P., Li, X., Chen, S. H., Wu, S. L., Wang, Z., & Lv, H. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004105
The return of “goals” in the 2026 ACC/AHA/Multisociety guideline on the management of dyslipidemia
Ahmad, Z., & Garg, A. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.006
Low-attenuation plaque-mediated NSTEMI in a patient with sarcoidosis and high Lp(a)
Venkat, R., Gill, E. A., & Kadiyala, M. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.014
Age-related metabolomic signatures and stroke susceptibility in a population-based cohort
Jiang, Y., Huang, Q., Li, J., Chen, Q., Li, J., Liu, Z., Cui, M., Suo, C., Xu, K., Li, J., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02374-w
N=1-studies In Statin-intolerance; Objectifying Nocebo Effects (NISONE): a study protocol for a randomised controlled trial assessing the implementability of N=1-studies to promote the use of statins
Mijnster, R. J. M., van Lennep, J. E. R., Rietdijk, W. J. R., Akgöl, K., Kemper, E. M., van den Berg, D. T. N. A., van der Kuy, P. H. M., & Lafeber, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110978
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials
Yang, Q., Bidel, Z., Canoy, D., Zeng, G., Cushman, W. C., Rodgers, A., Teo, K., Davis, B., Chalmers, J. P., Pepine, C. J., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04514-3
Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation
Björnson, E., & Adiels, M. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01442-y
Upregulation of miR-200b-3p serves as a diagnostic biomarker for coronary atherosclerosis and regulates the oxidized low-density lipoprotein cholesterol-induced dysfunction of vascular smooth muscle cells
Xia, Y., Gao, Y., Chai, F., Yan, L., & Lin, Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06289-4
„Vision Zero“ in der Prävention: Warum das Ziel, Krankheiten auf null reduzieren zu wollen, unser Gesundheitssystem gefährdet
Kühlein, T., Klemperer, D., & Scherer, M. (2026) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2026.07.001
Association of cumulative remnant cholesterol exposure with adverse outcomes after PCI in acute ST-segment elevation myocardial infarction
Sun, Y., Shao, F., Xu, X., Liu, Y., & Ma, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1842544
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women—A Prospective Study
Šojat, D., Pirić, M., Lukić, M., Horvat, V., Šafer, M., Feldi, I., Bačun, T., & Kibel, A. (2026) · Biomedicines · doi:10.3390/biomedicines14091921
Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia
Zhong, W., Zhang, J., Zhu, D., Pei, H., Wu, W., Huang, R., Yin, D., Gao, X., Li, B., Lv, C. Z., et al. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.07.017 · Cited by 1

Authors: Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L.
Affiliations: University of Cambridge (GB)
Trinity College Dublin (IE)
University of Milan (IT)
Corresponding author: Catapano, Alberico L.
ORCID: Graham, Ian
Catapano, Alberico L.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2018-09
Volume: 72
Issue: 10
Pages: 1141-1156
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2018.06.046
OpenAlex: W2889378692
Cited by: 511
References: 62
Citations by year: 2026: 65 · 2025: 75 · 2024: 82 · 2023: 80 · 2022: 68 · 2021: 76 · 2020: 35 · 2019: 29 · 2018: 1
FWCI: 7.83
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: ideal cardiovascular health, cardiovascular disease prevention, atherosclerosis, atherogenic lipoproteins, serum lipids, cardiovascular risk, care pathways
MeSH terms: Hypolipidemic Agents, Cardiovascular Diseases, Diet, Health Promotion, Humans, Lipids, Cholesterol, LDL, Primary Prevention, Genetic Variation, Exercise, Disease Progression, Genetic Predisposition to Disease, Atherosclerosis, Plaque, Atherosclerotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of Lipids on Cardiovascular Health

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks